SAN RAMON, Calif., Nov. 8 /PRNewswire/ -- BioGenex Laboratories, Inc. announced that the Xmatrx(TM), its new automated staining system, delivers “Microtome to Microscope” automation. The Xmatrx(TM) System automates fluorescence in situ hybridization (FISH), in situ hybridization (ISH) and immunohistochemistry (IHC), among other applications. From the initial baking of the tissue on the slide, the system automates all subsequent steps through the application of the coverslip at the end of a slide-based assay, resulting in a completely finished slide ready to go directly to the microscope or imaging system for review.
“We believe the Xmatrx(TM) System will cause a major shift in the field,” stated Krishan L. Kalra, Ph.D, Chairman and CEO of BioGenex. “It takes slides from the Microtome to Microscope -- it does not get more walkaway than this.”
Currently in limited release, the Xmatrx(TM) System will be available early in 2006.
About BioGenex
BioGenex, a technology leader in molecular pathology, provides Total Solution for complete automation of cell and tissue testing. The company offers a broad range of reagents and systems to streamline and standardize cellular and molecular diagnostics. BioGenex’s products are designed for high throughput at a low cost of ownership, providing ease of use and maximum flexibility for clinical diagnostics, life science research, and drug discovery.
BioGenex Laboratories, Inc.
CONTACT: media, Promila Rastogi, +1-925-866-2551, or financial, DavidSheldon, +1-925-543-1310, or business development, Shazi Iqbal,+1-925-866-2533, all for BioGenex Laboratories, Inc.
Web site: http://www.biogenex.com/
